Current Views on the Aetiology, Pathogenesis and Treatment of Acne Vulgaris

Drugs

Volumn 39, Issue 5, 1990, Pages 681-692

  Lever, Laurence ^a   Marks, Ronald ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CORYNEBACTERIUM; PROPIONIBACTERIUM ACNES;

ANTIANDROGEN; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; COTRIMOXAZOLE; CYPROTERONE ACETATE; DIANE; ERYTHROMYCIN; ESTROGEN; ETHINYLESTRADIOL; ISOTRETINOIN; MINOCYCLINE; RETINOIC ACID; RETINOID; SPIRONOLACTONE; TETRACYCLINE;

ACNE VULGARIS; CHEILITIS; DERMATITIS; DRUG RESISTANCE; FEMALE; HUMAN; INFLAMMATION; KERATINIZATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; SEBUM SECRETION; SKIN IRRITATION; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; CLINICAL PROTOCOLS; HUMAN;

EID: 0025280773     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199039050-00005     Document Type: Article

References (97)

1. Long-term antibiotic therapy for acne vulgaris: effects on the bowel flora of acne patients and their relatives
2. Cytotoxic activity of Propionibacterium acnesand other skin organisms
3. The production of inflammatory compounds by Propionibacterium acnesand other skin organisms
4. Topical therapy of acne
5. High dose tetracycline therapy in severe acne
6. The isotretinoin teratogen syndrome
7. Topical azaleic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracyline
8. Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne
9. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation
10. Roaccutane and menorrhagia. Correspondence
11. Chloracne (halogen acne)
12. Acne vulgaris: pathogenesis and treatment
13. Evolution of a strategy for the treatment of acne
14. Topical erythromycin: clinical and laboratory studies
15. Benzoyl peroxide: lack of sensitisation
16. Acne vulgaris — its aetiology and treatment: a review
17. Benzoyl peroxide in acne
18. The rate of sebum excretion in man
19. Topical benzoyl peroxide increases the sebum excretion rate in patients with acne
20. The effect of tetracycline and erythromycin in a model of acne-type inflammation
21. Recent advances in hormonal aspects of acne vulgaris
22. Essential fatty acids and acne
23. Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment
24. Should topical antibiotics be used for the treatment of acne vulgaris?
25. A double-blind comparative study of benzoyl peroxide, benzoyl peroxide-chlorhydroxyquinolone, benzoyl peroxide-chlorhydroxyquinolone-hydrocortisone and placebo lotions in acne
26. In vivosuppression of neutrophil chemotaxis by systemically and topically administered tetracycline
27. Induction of colitis in hamsters by topical application of antibiotics
28. Adverse reactions to topical clindamycin, erythromycin and tetracycline
29. Effect of tetracycline on the composition of sebum in acne
30. Comedogenicity of current therapeutic products, cosmetics and ingredients in the rabbit ear
31. Isotretinoin in the treatment of acne: histologic changes, sebum production and clinical observations
32. Oral spirono-lactone improves acne vulgaris and reduces sebum excretion
33. Spironolactone and cimetidine in treatment of acne
34. Effect of 13-cis-retinoic acid on inflammatory responses in acne vulgaris
35. The tolerance of spironolactone
36. Acne vulgaris: current concepts of pathogenesis and treatment
37. The localisation and distribution of Corynebacterium acnesand its antigens in normal skin and in lesions of acne vulgaris
38. Topical erythromycin versus blank vehicle in a multicentre study
39. Topical vitamin A acid in acne vulgaris
40. Acne cosmetica
41. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions
42. The relationship between bacteria and the abnormal follicular keratinisation in acne vulgaris
43. Acne and oral contraceptives
44. Acne and serum androgens during puberty
45. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris
46. A single-blind comparative study of doxycycline 50mg daily versus oxytetracycline 500mg twice daily in the management of inflammatory acne vulgaris
47. Clostridium difficileand pseudomembranous colitis — the association with antibiotic therapy and with long-term treatment of acne
48. Absorption of minocycline hydrochloride and tetra-cycline hydrochloride
49. Propionibacterium acnesresistance to antibiotics in acne patients
50. Pseudomonas aeruginosagram-negative folliculitis
51. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris
52. Tissue production of androgen in women with acne
53. Skeletal changes associated with chronic isotretinoin and etretinate administration
54. Inflammation caused by intra-cutaneous implantation of stratum corneium
55. The microflora of the face and acne lesions
56. Androgen excess in cystic acne
57. Current concepts. Topical therapy for acne
58. Is sulphur helpful or harmful in acne vulgaris?
59. The clinical effectiveness of topical erythromycin in acne vulgaris
60. Pseudomembranous colitis after topical application of clindamycin
61. Comparative activity of benzoyl peroxide and hexachloraphane: in vivostudies against Propionibacterium acnesin humans
62. Benzoyl peroxide: percutaneous penetration and metabolic disposition
63. Topical retinoic acid in the treatment of acne vulgaris
64. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid
65. Topical retinoic acid in acne vulgaris
66. Retinoid hyperostosis
67. Sebum production, casual sebum levels, titratable acidity of sebum and urinary fractional 17-ketosteroid excretion in males with acne
68. Skin surface lipid composition, acne, pubertal development and urinary excretion of testosterone and 17-ketosteroids in children
69. The chemoattractant properties of comedonal components
70. Patient’s concepts and misconceptions about acne
71. Pilosebaceous physiology in relation to hirsutism and acne
72. Minocycline treatment of tetracycline-resistant and tetracycline-responsive acne vulgaris
73. Safety of long-term tetracycline for acne
74. Genesis of free fatty acids
75. Isotretinoin treatment of acne and related disorders: an update
76. Effects of topical clindamycin on intestinal microflora in patients with acne
77. Hypervitaminosis A syndrome: a paradigm of retinoid side effects
78. Tetracycline in acne vulgaris
79. The effect of changes in sebaceous gland activity on the fatty acid composition of sebum
80. The effect of 13-cis-retinoic acid on sebaceous glands
81. The therapeutic uses of topical vitamin A acid
82. Acne of the fulminans type following testosterone therapy in three excessively tall boys
83. Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material
84. Genetic control of sebum excretion and acne — a twin study
85. Isotretinoin: a review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders
86. Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis-retinoic acid
87. Chlorhydroxyquinbenzoyl peroxide lotion in the treatment of acne: an objective evaluation